Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Narendran

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
The American Journal of Psychiatry|April 4, 2007
Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaineDiana Martinez, Rajesh Narendran, Richard W Foltin, et al.
Synapse (New York, N.Y.)|April 6, 2004
In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-racloprideRajesh Narendran, Dah-Ren Hwang, Mark Slifstein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2009
Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaineDiana Martinez, Mark Slifstein, Rajesh Narendran, et al.
The American Journal of Psychiatry|December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersRajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Translational Psychiatry|May 2, 2021
Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [<sup>11</sup>C]PIB PET studyMargaret R Flanigan, Sarah K Royse, David P Cenkner, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
Synapse (New York, N.Y.)|May 28, 2010
No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortexW Gordon Frankle, N Scott Mason, Eugenii A Rabiner, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
The American Journal of Psychiatry|April 4, 2007
Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaineDiana Martinez, Rajesh Narendran, Richard W Foltin, et al.
Synapse (New York, N.Y.)|April 6, 2004
In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-racloprideRajesh Narendran, Dah-Ren Hwang, Mark Slifstein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2009
Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaineDiana Martinez, Mark Slifstein, Rajesh Narendran, et al.
The American Journal of Psychiatry|December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersRajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Translational Psychiatry|May 2, 2021
Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [<sup>11</sup>C]PIB PET studyMargaret R Flanigan, Sarah K Royse, David P Cenkner, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
Synapse (New York, N.Y.)|May 28, 2010
No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortexW Gordon Frankle, N Scott Mason, Eugenii A Rabiner, et al.
Pageof 7